Document is current
Any future updates will be listed below
-
Authors
Pfefferle, Aline https://orcid.org/0000-0002-8181-537X
Phuyal, Santosh https://orcid.org/0000-0002-1922-2098
Netskar, Herman
Malmberg, Karl-Johan https://orcid.org/0000-0002-8718-9373
-
Funding
Funding for this research was provided by:
Norges Forskningsråd (275469)
Norges Forskningsråd (237579)
Norges Forskningsråd (332727)
Kreftforeningen (223310)
Vetenskapsrådet
- License Information
-
More Information
Article History
Received: 27 May 2024
Accepted: 29 May 2024
First Online: 17 June 2024
Disclosure and competing interests statement
: KJM is a consultant at Fate Therapeutics and Vycellix and has research support from Oncopeptides for studies unrelated to this work. The remaining authors declare no competing interests.
